Doxapram Pregnancy and Breastfeeding Warnings
Brand names: Dopram
Doxapram Pregnancy Warnings
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: B
Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy.
US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Doxapram Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2001) "Product Information. Dopram (doxapram)." West Ward Pharmaceutical Corporation
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- (2020) "Product Information. Dopram (doxapram)." Hikma USA (formerly West-Ward Pharmaceutical Corporation)
References for breastfeeding information
- (2001) "Product Information. Dopram (doxapram)." West Ward Pharmaceutical Corporation
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.